| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 250 | 2021 |
| Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France LL Mariani, P Lozeron, M Théaudin, Z Mincheva, A Signate, B Ducot, ... Annals of neurology 78 (6), 901-916, 2015 | 179* | 2015 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 177 | 2020 |
| Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease H You, LL Mariani, G Mangone, D Le Febvre de Nailly, ... Cell and tissue research 373, 111-135, 2018 | 81 | 2018 |
| Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy P Lozeron, LL Mariani, P Dodet, G Beaudonnet, M Théaudin, C Adam, ... Neurology 91 (2), e143-e152, 2018 | 77 | 2018 |
| Treatment for dystonia in childhood A Roubertie, LL Mariani, E Fernandez‐Alvarez, D Doummar, E Roze European journal of neurology 19 (10), 1292-1299, 2012 | 71 | 2012 |
| Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach LL Mariani, C Tesson, P Charles, C Cazeneuve, V Hahn, K Youssov, ... JAMA neurology 73 (9), 1105-1114, 2016 | 55 | 2016 |
| Exonic deletions of FXN and early-onset Friedreich ataxia M Anheim, LL Mariani, P Calvas, E Cheuret, F Zagnoli, S Odent, ... Archives of neurology 69 (7), 912-916, 2012 | 52 | 2012 |
| Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19 V Lambrecq, A Hanin, E Munoz-Musat, L Chougar, S Gassama, ... JAMA Network Open 4 (3), e211489-e211489, 2021 | 43 | 2021 |
| Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting L Chougar, J Faouzi, N Pyatigorskaya, L Yahia‐Cherif, R Gaurav, ... Movement Disorders 36 (2), 460-470, 2021 | 40 | 2021 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| Long-term effect of apomorphine infusion in advanced Parkinson’s disease: A real-life study B Meira, B Degos, E Corsetti, M Doulazmi, E Berthelot, ... npj Parkinson's Disease 7 (1), 50, 2021 | 31 | 2021 |
| Loss‐of‐Function Mutations in NR4A2 Cause Dopa‐Responsive Dystonia Parkinsonism T Wirth, LL Mariani, G Bergant, M Baulac, MO Habert, N Drouot, E Ollivier, ... Movement Disorders 35 (5), 880-885, 2020 | 28 | 2020 |
| Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein LL Mariani, S Rivaud-Péchoux, P Charles, C Ewenczyk, A Meneret, ... Scientific Reports 7 (1), 15284, 2017 | 25 | 2017 |
| The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre C Delorme, M Houot, C Rosso, S Carvalho, T Nedelec, R Maatoug, ... Brain communications 3 (3), fcab135, 2021 | 23 | 2021 |
| Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial JC Corvol, F Durif, WG Meissner, JP Azulay, R Haddad, ... Parkinsonism & related disorders 60, 51-56, 2019 | 20 | 2019 |
| Treatable hyperkinetic movement disorders not to be missed A Méneret, B Garcin, S Frismand, LL Mariani Frontiers in neurology 12, 659805, 2021 | 18 | 2021 |
| Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management J Faouzi, JC Corvol, LL Mariani Current opinion in neurology 34 (4), 547-555, 2021 | 16 | 2021 |
